The Use of Hydroxyapatite Cement Implant In Human Interproximal Periodontal Defects.
Abstract
A new type of calcium phosphate cement (Hydroxyapatite Cement) has shown promise in the treatment of craniofacial defects. Sixteen patients with moderate to severe periodontal disease and 2 bilaterally similar vertical bony defects received initial therapy including scaling and root planing. Baseline clinical measurements recorded 4-weeks post-initial therapy included probing depth and clinical attachment levels utilizing a probing stent and conventional probe. In a split mouth design, all patients received the test material (Hydroxyapatite Cement) in one defect and either flap curettage only (negative control) or demineralized freeze-dried bone allograft (positive control) in the contralateral defect.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jan 09, 1997
- Accession Number
- ADA320198
Entities
People
- Craig D. Brown
Organizations
- Air Force Institute of Technology